Vbi Vaccines Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2024 to a ratio of 57.12, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2024. Average receivable collection period, for the Vbi Vaccines Inc in Mar 31 2024 quarter, has decreased to 6 days, compared to 7 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 503 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2024 from 3086 to 3224.

What is Receivable Turnover Ratio?
What is Vbi Vaccines Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VBIV Receivables Turnover Ratio	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Receivable Change	-19.22 %	-	167.42 %	-41.48 %	175.49 %
Y / Y Revenue Change	150.31 %	191.13 %	1989.59 %	108.09 %	284.92 %
Receivable Turnover Ratio (TTM)	57.12	48.71	40.26	12.39	8.98
VBIV's Total Ranking	# 3224	# 3086	# 353	# 3131	# 3455
Accounts Receivable average collection period days	6	7	9	29	41
Seq. Receivable Change	-	-	346.84 %	-71.89 %	198.94 %
Seq. Revenue Change	42.32 %	-87.12 %	820 %	48.45 %	65.53 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 183
Healthcare Sector	# 504
Overall Market	# 3224

Receivable Turnover Ratio Statistics
High	Average	Low
0.83	0.09	0
(June 30. 2014)		(Mar 31 2022)

VBIV Company Profile • Back to VBIV Efficiency Comparisons • Compare VBIV Receivables Turnover Ratio to its Competitors

Financial Statements
Vbi Vaccines Inc's Accounts Receivable	$ 0 Millions	Visit VBIV's Balance sheet
Vbi Vaccines Inc's Sales TTM	$ 9 Millions	Visit VBIV's Income Statement
Sources of VBIV's Revenues		Visit VBIV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VBIV's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VBIV's Growth Rates	VBIV's Roa	VBIV's Inventory Turnover Ratio	VBIV's Dividend Comparisons
VBIV's Profitability Ratios	VBIV's Roi	VBIV's Asset Turnover Ratio	VBIV's Dividend Growth
VBIV's Valuation Ratios	VBIV's Roe	VBIV's Financial Strength Ratios	VBIV's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
Orthofix Medical Inc	102.50	$ 759.311 Millions	$ 7.408 Millions
Stoke Therapeutics Inc	102.20	$ 7.844 Millions	$ 0.077 Millions
Lifevantage Corp	92.45	$ 204.649 Millions	$ 2.214 Millions
Aclaris Therapeutics Inc	85.96	$ 31.119 Millions	$ 0.362 Millions
Airsculpt Technologies Inc	85.94	$ 197.724 Millions	$ 2.301 Millions
Lipocine Inc	84.79	$ 4.613 Millions	$ 0.054 Millions
Zeo Scientifix Inc	84.50	$ 4.928 Millions	$ 0.058 Millions
Takeda Pharmaceutical Company Limited	83.25	$ 29,166.692 Millions	$ 350.335 Millions
Agape Atp Corporation	82.24	$ 1.369 Millions	$ 0.017 Millions
Lucid Diagnostics Inc	79.55	$ 2.983 Millions	$ 0.038 Millions
Longduoduo Co Ltd	77.88	$ 8.777 Millions	$ 0.113 Millions
Pavmed Inc	67.75	$ 3.472 Millions	$ 0.051 Millions
Ontrak Inc	65.04	$ 11.951 Millions	$ 0.184 Millions
Brookdale Senior Living Inc	62.86	$ 3,045.397 Millions	$ 48.446 Millions
Vbi Vaccines Inc	57.12	$ 9.411 Millions	$ 0.165 Millions
Janux Therapeutics Inc	56.16	$ 7.287 Millions	$ 0.130 Millions
Nature s Sunshine Products inc	44.22	$ 447.471 Millions	$ 10.120 Millions
Nektar Therapeutics	43.14	$ 90.167 Millions	$ 2.090 Millions
Renalytix Plc	43.00	$ 5.106 Millions	$ 0.119 Millions
Dih Holding Us Inc	40.01	$ 108.887 Millions	$ 2.721 Millions
Marpai Inc	39.39	$ 34.672 Millions	$ 0.880 Millions
Vivos Therapeutics Inc	38.54	$ 12.351 Millions	$ 0.321 Millions
Spero Therapeutics Inc	38.14	$ 110.979 Millions	$ 2.910 Millions
Cano Health Inc	36.41	$ 2,955.274 Millions	$ 81.171 Millions
Electrocore Inc	35.44	$ 17.889 Millions	$ 0.505 Millions
Lifemd Inc	34.57	$ 161.635 Millions	$ 4.675 Millions
Invo Fertility Inc	33.38	$ 4.249 Millions	$ 0.127 Millions
Prothena Corporation Public Limited Company	32.93	$ 89.251 Millions	$ 2.710 Millions
23andme Holding Co	32.38	$ 219.377 Millions	$ 6.776 Millions
Sonida Senior Living Inc	30.60	$ 260.687 Millions	$ 8.518 Millions

Date modified: 2026-09-08T15:11:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.